Portal hypertension is associated with poor outcome of transarterial chemoembolization in patients with hepatocellular carcinoma
Abstract
To determine whether clinically relevant portal hypertension (CRPH) influences outcome and whether it may serve as a prognostic marker in patients treated with transarterial chemoembolization (TACE) for hepatocellular carcinoma (HCC). One hundred and forty-seven patients underwent conventional TACE as a first-line treatment for a single HCC. CRPH was graded as 0, 1, or 2. The influence of CRPH, together with other factors, on local tumour...
Paper Details
Title
Portal hypertension is associated with poor outcome of transarterial chemoembolization in patients with hepatocellular carcinoma
Published Date
Dec 7, 2017
Journal
Volume
28
Issue
5
Pages
2184 - 2193
Citation AnalysisPro
You’ll need to upgrade your plan to Pro
Looking to understand the true influence of a researcher’s work across journals & affiliations?
- Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
- Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.
Notes
History